The Form 144 signals intent to sell, but the small size relative to market cap and the director's role suggest routine portfolio diversification. Monitor for actual sale on Form 4; no material impact expected.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 2 $19.49entry
- T+1 · 7d ago +5.95%α +5.65% · $20.65
- T+5 · yesterday +14.21%α +14.13% · $22.26
- T+6 · todayOpen
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Director Veleka Peeples-Dyer filed a Form 144 notice of intent to sell 10,000 shares of Replimune Group common stock, valued at approximately $167,232 based on the filing date price. The shares were acquired via a stock option exercise on the same day. The proposed sale represents a small fraction of the company's $1.5B market cap and is a routine insider transaction.
Key Facts
- Director Veleka Peeples-Dyer filed Form 144 to sell 10,000 shares of REPL common stock.
- Estimated value of proposed sale: $167,232.
- Shares were acquired via stock option exercise on the same day (10/30/2026).
- The sale is proposed to occur on or after 10/30/2026 on Nasdaq.
- The filer also reported holding 12,000 shares acquired on 10/28/2026.
- Company market cap is $1.5B; the sale is approximately 0.01% of market cap.
Financial Impact
Proposed sale of 10,000 shares valued at ~$167,232, representing a minimal fraction of the company's $1.5B market cap.
Risk Factors
- Insider selling could be perceived negatively if it precedes negative news, though the small size mitigates this risk.
- The filing is an intent to sell; the actual sale may not occur.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010514 |
| Document: 0001950047-26-010514-index.html | 0001950047-26-010514 |
| Document: 0001950047-26-010514.txt | 0001950047-26-010514 |
Track record
31 reports on REPL
9 of 13 bullish or bearish reports moved the stock their way by T+60. Best: +188.35% at T+20 after the Jul 30, 2026 report. 13 of 14 went positive at some point.
Filters
- Nov 10, 2026today Insider Cluster Neutral 2/10 Entry $23.47 Now $23.28 −0.81% settles Feb 9
- Nov 10, 2026today SC 13G Neutral 3/10 Entry $22.00 Now $23.28 +5.82% settles Feb 8
- Nov 9, 20261d ago 144 Neutral 2/10 Entry $22.51 Now $23.28 +3.42% settles Feb 8
- Nov 9, 20261d ago SC 13G/A Neutral 2/10 Entry $22.26 Now $23.28 +4.58% settles Feb 5
- Nov 6, 20264d ago 10-Q/A Neutral 3/10 Entry $22.26 Now $23.28 +4.58% settles Feb 5
- Nov 4, 20266d ago Institutional Cluster Bearish 4/10 Entry $20.69 Now $23.28 −12.52% settles Feb 2
- Nov 3, 20267d ago 144 Neutral 2/10 Entry $20.69 Now $23.28 +12.52% settles Feb 2
- Nov 2, 20268d ago 144 Neutral 2/10 Entry $20.65 Now $23.28 +12.74% settles Feb 1
- Oct 30, 202611d ago 144 Neutral 2/10 Viewing Entry $19.49 Now $23.28 +19.45% settles Jan 29
- Oct 28, 202613d ago 144 Neutral 2/10 Entry $17.39 Now $23.28 +33.87% settles Jan 27
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers